Anal cancer in the HIV-positive patient: An escalating problem in the era of HAART

HIV and AIDS Review

Volumn 5, Issue 2, 2006, Pages 51-56

  Schlecht, Hans P ^a   Pantanowitz, Liron ^b   Dezube, Bruce J ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anal cancer; HAART; HIV

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN; PACLITAXEL; ZIDOVUDINE;

ANUS CANCER; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROGNOSIS; REVIEW;

EID: 34249051058     PISSN: 17301270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Overview: Anal Cancer: How many people get anal cancer? 10 Mar. 2006. American Cancer Society. 28 Mar. 2006. www.cancer.org/docroot/CRI/content
2. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999; 85(8): 1686-93.
3. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994; 139(8): 772-80.
4. Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101(2): 281-8.
5. Tolmos J, Vargas HI, Lim S, Stamos M. A forty-year experience with anal carcinoma: changing trends and impact of multimodality therapy. Am Surg 1997; 63(10): 918-22.
6. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317(16): 973-7.
7. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351(9119): 1833-9.
8. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92(18): 1500-10.
9. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35(9): 1127-34.
10. Buckwalter JA, Jurayj MN. Relationship of chronic anorectal disease to carcinoma. AMA Arch Surg 1957; 75(3): 352-60.
11. Kline RJ, Spencer RJ, Harrison EG Jr. Carcinoma associated with fistula-in-ano. Arch Surg 1964; 89: 989-94.
12. Slater G, Greenstein A, Aufses AH Jr. Anal carcinoma in patients with Crohn's disease. Ann Surg 1984; 199(3): 348-50.
13. Preston DM, Fowler EF, Lennard-Jones JE, Hawley PR. Carcinoma of the anus in Crohn's disease. Br J Surg 1983; 70(6): 346-7.
14. Holly EA, Whittemore AS, Aston DA, et al. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989; 81(22): 1726-31.
15. Frisch M, Olsen JH, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer. N Engl J Med 1994; 331(5): 300-2.
16. Frisch M, Glimelius B, van den Brule AJ, et al. Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma. Br J Cancer 1998; 78(11): 1534-8.
17. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer 2000; 83(1): 89-90.
18. Daling JR, Weiss NS, Klopfenstein LL, et al. Correlates of homosexual behavior and the incidence of anal cancer. JAMA 1982; 247(14): 1988-90.
19. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997. 337(19): 1350-8.
20. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Patholo 1999; 189(1):12-9.
21. Trimble CL, Hildesheim CA, Brinton LA, et al. Heterogeneous etiology of squamous cell carcinoma of the vulva. Obstet Gynecol 1996; 87(1): 59-64.
22. Gregoire L, Cubilla AL, Reuter VE, et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995; 87(22): 1705-9.
23. Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991; 338(8768): 657-9.
24. Palefsky JM, Holly EA, Gonzales J, et al. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res 1991; 51(3): 1014-9.
25. Frisch M, Fenger C, van der Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999; 59(3): 753-7.
26. Lee SH, McGregor DH, Kuziez MN. Malignant transformation of perianal condyloma acuminatum: a case report with review of the literature. Dis Colon Rectum 1981; 24(6): 462-7.
27. Metcalf AM, Dean T. Risk of dysplasia in anal condyloma. Surgery 1995; 118(4): 724-6.
28. Anderson CA, Boller AM, Richardson CJ, et al. Anal condyloma: a comparison between HIV positive and negative patients. Am Surg 2004; 70(11): 1014-8.
29. Papaconstantinou HT, Lee AJ, Simmang CL, et al. Screening methods for high-grade dysplasia in patients with anal condyloma. J of Surg Res 2005; 127(1): 8-13.
30. Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003; 31: 41-6.
31. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004; 37(5): 1563-5.
32. Diamond C, Taylor TH, Aboumrad T, et al. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005; 32(5): 314-20.
33. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135(2): 180-9.
34. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101(2): 270-80.
35. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol 1992; 136(1): 54-8.
36. Blohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation 1985; 39(1): 23-5.
37. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1986; 58(3): 611-6.
38. Sillman FH, Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women: an update. Dermatol Clin 1991; 9(2): 353-69.
39. Arends MJ, Benton EC, McLaren KM, et al. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997; 75(5): 722-8.
40. Wendell-Smith CP. Anorectal nomenclature. Fundamental terminology. Dis Colon Rectum 2000; 43(10): 1349-58.
41. Singh R, Nime F, Mittelman A. Malignant epithelial tumors of the anal canal. Cancer 1981; 48(2): 411-5.
42. Schneider TC, Schulte WJ. Management of carcinoma of anal canal. Surgery 1981; 90(4): 729-34.
43. Schraut WH, Wang CH, Dawson PJ, Block GE. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer 1983; 51(7): 1291-6.
44. Chadha M, Rosenblatt EA, Malamud S, et al. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 1994; 37(9): 861-5.
45. Frost DB, Richards PC, Montague ED, et al. Epidermoid cancer of the anorectum. Cancer 1984; 53(6): 1285-93.
46. Boman BM, Moertel CG, O'Connell MJ, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984(1); 54: 114-25.
47. Klotz RG, Pamukcoglu T, Souiliard DH. Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases. Cancer 1967; 20(10): 1727-45.
48. Greenall MJ, Quan SH, Stearns MW, et al. Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results. Am J Surg 1985; 149(1): 95-101.
49. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 1994; 73(6):1569-79.
50. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17(3):354-6.
51. Leichman L, Nigro N, Vaitkevicius VK, et al. Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med 1985; 78(2): 211-5.
52. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15(5): 2040-9.
53. Flam M, John M, Pajak TF, et al. Role of mitomycine in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996; 14(9): 2527-39.
54. Hoffman R, Welton ML, Klencke B, et al. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 1999; 44(1): 127-31.
55. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 2001; 44(10): 1496-502.
56. Place RJ, Gregorcyk SG, Huber PJ, et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001; 44(4): 506-12.
57. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976; 184(4): 422-8.
58. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996; 348(9034): 1049.
59. Smith AJ, Whelan P, Cummings BJ, Stern HS. Management of persistent or locally recurrent epidermoid cancer of the anal canal with abdominoperineal resection. Acta Oncol 2001; 40(1): 34-6.
60. Longo WE, Vernava AM, Wade TP, et al. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 1994; 220(1): 40-9.
61. Allal AS, Laurencet FM, Reymond MA, et al. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999; 86(3): 405-9.
62. Faynsod M, Vargas HI, Tolmos J, et al. Patterns of recurrence in anal canal carcinoma. Arch Surg 2000; 135(9): 1090-3.
63. Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005; 92(5): 605-14.
64. Tanum G. Treatment of relapsing anal carcinoma. Acta Oncol 1993; 32(1): 33-5.
65. Ajani JA, Carrasco CH, Jackson DE, Wallace S. Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 1989; 87(2): 221-4.
66. Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M. Chemotherapy and radiation therapy for anal carcinoma: Survival and late morbidity. Cancer 1991; 67(10): 2462-6.
67. Biggar RJ, Engels EA, Ly S, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005; 39(3): 293-9.
68. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6(5): 271-8.
69. Panther LA, Schlecht HP, Dezube BJ. The spectrum of human papilloma-related dysplasia and carcinoma of the anus in HIV-infected patients. AIDS Reader 2004; 15(2): 79-82, 85-6, 88, 91.